Carnegie Investment Counsel Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Carnegie Investment Counsel grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 92.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,253 shares of the medical equipment provider’s stock after purchasing an additional 1,565 shares during the period. Carnegie Investment Counsel’s holdings in Intuitive Surgical were worth $1,500,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Draper Asset Management LLC lifted its position in shares of Intuitive Surgical by 41.9% during the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after acquiring an additional 1,485 shares in the last quarter. Deutsche Bank AG grew its position in shares of Intuitive Surgical by 9.6% in the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock valued at $862,108,000 after purchasing an additional 132,966 shares in the last quarter. Oppenheimer Asset Management Inc. grew its position in shares of Intuitive Surgical by 29.3% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock valued at $40,255,000 after purchasing an additional 16,119 shares in the last quarter. Procyon Advisors LLC raised its stake in shares of Intuitive Surgical by 787.8% during the 4th quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock valued at $2,715,000 after purchasing an additional 4,254 shares during the period. Finally, Robinhood Asset Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $6,478,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $407.12 on Tuesday. The company’s fifty day moving average price is $421.09 and its 200-day moving average price is $472.71. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The firm has a market capitalization of $144.19 billion, a price-to-earnings ratio of 49.35, a PEG ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter in the prior year, the company earned $1.81 EPS. The firm’s revenue was up 23.0% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen kept a Buy rating on Intuitive Surgical while trimming its price target from $585 to $520, signaling that the analyst still sees upside despite a more conservative valuation view. TD Cowen lowers ISRG price target to $520
• Positive Sentiment: Royal Bank of Canada also lowered its target, from $650 to $600, but maintained an Outperform rating, reinforcing a constructive outlook ahead of earnings. RBC lowers ISRG price target to $600
• Positive Sentiment: Multiple articles highlighted Intuitive Surgical as a leading robotics and automation name for the second half of 2026, with investors viewing the company as a beneficiary of AI-enabled surgical robotics growth. Zacks robotics stock list mentions ISRG
• Positive Sentiment: Bearish recent performance has made the stock look more attractive to some analysts, with coverage pieces arguing ISRG could offer roughly 35% upside before earnings if management confirms solid demand and margins. 247WallSt ISRG upside article
• Neutral Sentiment: Intuitive Surgical is expected to report second-quarter EPS of about $2.50 on revenue near $2.82 billion after the close on July 16, with investors likely waiting for results and guidance before making a bigger move. ISRG earnings preview
• Negative Sentiment: The main negative takeaway is that both TD Cowen and RBC reduced their price targets, which suggests analysts are becoming a bit more cautious on valuation even while staying bullish overall.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday. Truist Financial cut their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Finally, Bank of America decreased their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $562.12.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director owned 239 shares in the company, valued at $113,156.94. The trade was a 67.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.